Medifast MED Optavia Segment — Net loss

Similar metrics at other companies

CHE

CHESegment Vitas — Net Income Loss

$52.21M+4.4%

ACVAACV Segment — Net loss

-$10.89M+26.5%

CHE

CHESegment Vitas — Operating Income

$62.45M-0.5%

SRPTAll Other Segments — Net Income Loss

$330.96M+174%

BOTJAll Other Segments — Net Income Loss

$2.26M+13.6%

NBT

NBTBAll Other Segments — Net Income Loss

$926K-40.5%

Questions, answered.

What is Medifast's optavia segment — net loss?

Medifast (MED) reported optavia segment — net loss of -$2.12M in Q1 2026.

How has Medifast's optavia segment — net loss changed year-over-year?

Medifast's optavia segment — net loss decreased by 174.9% year-over-year, from -$772K to -$2.12M.

What is the long-term trend for Medifast's optavia segment — net loss?

Over 3 years (2022 to 2025), Medifast's optavia segment — net loss has grown at a -49.3% compound annual growth rate (CAGR), from $143.57M to -$18.67M.

What does optavia segment — net loss mean?

Indicates the bottom-line financial performance of the Optavia segment after all operating expenses, taxes, and non-operating items have been deducted. A net loss signifies that the segment's costs exceeded its revenues during the reporting period, highlighting potential sustainability challenges.